The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prostate Cancer Diagnosis and Therapy Market Research Report 2025
Synopsis
The global Prostate Cancer Diagnosis and Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnosis and Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnosis and Therapy.
Report Scope
The Prostate Cancer Diagnosis and Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer Diagnosis and Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Diagnosis and Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Astellas Pharma
AstraZeneca
Bayer
Dendreon Pharmaceuticals
Ferring
Ipsen Pharma
Johnson and Johnson
Sanofi
Tolmar Pharmaceuticals
Segment by Type
Hormone Therapy
Chemotherapy
Biologic Therapy
Targeted Therapy
Segment by Application
General Hospitals
Specialty Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Diagnosis and Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Prostate Cancer Diagnosis and Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnosis and Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnosis and Therapy.
Report Scope
The Prostate Cancer Diagnosis and Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer Diagnosis and Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Diagnosis and Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Astellas Pharma
AstraZeneca
Bayer
Dendreon Pharmaceuticals
Ferring
Ipsen Pharma
Johnson and Johnson
Sanofi
Tolmar Pharmaceuticals
Segment by Type
Hormone Therapy
Chemotherapy
Biologic Therapy
Targeted Therapy
Segment by Application
General Hospitals
Specialty Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Diagnosis and Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Diagnosis and Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hormone Therapy
1.2.3 Chemotherapy
1.2.4 Biologic Therapy
1.2.5 Targeted Therapy
1.3 Market by Application
1.3.1 Global Prostate Cancer Diagnosis and Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 General Hospitals
1.3.3 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Diagnosis and Therapy Market Perspective (2019-2030)
2.2 Prostate Cancer Diagnosis and Therapy Growth Trends by Region
2.2.1 Global Prostate Cancer Diagnosis and Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Prostate Cancer Diagnosis and Therapy Historic Market Size by Region (2019-2024)
2.2.3 Prostate Cancer Diagnosis and Therapy Forecasted Market Size by Region (2025-2030)
2.3 Prostate Cancer Diagnosis and Therapy Market Dynamics
2.3.1 Prostate Cancer Diagnosis and Therapy Industry Trends
2.3.2 Prostate Cancer Diagnosis and Therapy Market Drivers
2.3.3 Prostate Cancer Diagnosis and Therapy Market Challenges
2.3.4 Prostate Cancer Diagnosis and Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Diagnosis and Therapy Players by Revenue
3.1.1 Global Top Prostate Cancer Diagnosis and Therapy Players by Revenue (2019-2024)
3.1.2 Global Prostate Cancer Diagnosis and Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Prostate Cancer Diagnosis and Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Diagnosis and Therapy Revenue
3.4 Global Prostate Cancer Diagnosis and Therapy Market Concentration Ratio
3.4.1 Global Prostate Cancer Diagnosis and Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnosis and Therapy Revenue in 2023
3.5 Prostate Cancer Diagnosis and Therapy Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Diagnosis and Therapy Product Solution and Service
3.7 Date of Enter into Prostate Cancer Diagnosis and Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Diagnosis and Therapy Breakdown Data by Type
4.1 Global Prostate Cancer Diagnosis and Therapy Historic Market Size by Type (2019-2024)
4.2 Global Prostate Cancer Diagnosis and Therapy Forecasted Market Size by Type (2025-2030)
5 Prostate Cancer Diagnosis and Therapy Breakdown Data by Application
5.1 Global Prostate Cancer Diagnosis and Therapy Historic Market Size by Application (2019-2024)
5.2 Global Prostate Cancer Diagnosis and Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Prostate Cancer Diagnosis and Therapy Market Size (2019-2030)
6.2 North America Prostate Cancer Diagnosis and Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Prostate Cancer Diagnosis and Therapy Market Size by Country (2019-2024)
6.4 North America Prostate Cancer Diagnosis and Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Diagnosis and Therapy Market Size (2019-2030)
7.2 Europe Prostate Cancer Diagnosis and Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Prostate Cancer Diagnosis and Therapy Market Size by Country (2019-2024)
7.4 Europe Prostate Cancer Diagnosis and Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size (2019-2030)
8.2 Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Cancer Diagnosis and Therapy Market Size (2019-2030)
9.2 Latin America Prostate Cancer Diagnosis and Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Prostate Cancer Diagnosis and Therapy Market Size by Country (2019-2024)
9.4 Latin America Prostate Cancer Diagnosis and Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size (2019-2030)
10.2 Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Prostate Cancer Diagnosis and Therapy Introduction
11.1.4 AbbVie Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Detail
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Prostate Cancer Diagnosis and Therapy Introduction
11.2.4 Astellas Pharma Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
11.2.5 Astellas Pharma Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Prostate Cancer Diagnosis and Therapy Introduction
11.3.4 AstraZeneca Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
11.3.5 AstraZeneca Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Prostate Cancer Diagnosis and Therapy Introduction
11.4.4 Bayer Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
11.4.5 Bayer Recent Development
11.5 Dendreon Pharmaceuticals
11.5.1 Dendreon Pharmaceuticals Company Detail
11.5.2 Dendreon Pharmaceuticals Business Overview
11.5.3 Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Introduction
11.5.4 Dendreon Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
11.5.5 Dendreon Pharmaceuticals Recent Development
11.6 Ferring
11.6.1 Ferring Company Detail
11.6.2 Ferring Business Overview
11.6.3 Ferring Prostate Cancer Diagnosis and Therapy Introduction
11.6.4 Ferring Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
11.6.5 Ferring Recent Development
11.7 Ipsen Pharma
11.7.1 Ipsen Pharma Company Detail
11.7.2 Ipsen Pharma Business Overview
11.7.3 Ipsen Pharma Prostate Cancer Diagnosis and Therapy Introduction
11.7.4 Ipsen Pharma Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
11.7.5 Ipsen Pharma Recent Development
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Detail
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Prostate Cancer Diagnosis and Therapy Introduction
11.8.4 Johnson and Johnson Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
11.8.5 Johnson and Johnson Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Prostate Cancer Diagnosis and Therapy Introduction
11.9.4 Sanofi Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
11.9.5 Sanofi Recent Development
11.10 Tolmar Pharmaceuticals
11.10.1 Tolmar Pharmaceuticals Company Detail
11.10.2 Tolmar Pharmaceuticals Business Overview
11.10.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Introduction
11.10.4 Tolmar Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
11.10.5 Tolmar Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Prostate Cancer Diagnosis and Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Hormone Therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Biologic Therapy
Table 5. Key Players of Targeted Therapy
Table 6. Global Prostate Cancer Diagnosis and Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Prostate Cancer Diagnosis and Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Prostate Cancer Diagnosis and Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Prostate Cancer Diagnosis and Therapy Market Share by Region (2019-2024)
Table 10. Global Prostate Cancer Diagnosis and Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Prostate Cancer Diagnosis and Therapy Market Share by Region (2025-2030)
Table 12. Prostate Cancer Diagnosis and Therapy Market Trends
Table 13. Prostate Cancer Diagnosis and Therapy Market Drivers
Table 14. Prostate Cancer Diagnosis and Therapy Market Challenges
Table 15. Prostate Cancer Diagnosis and Therapy Market Restraints
Table 16. Global Prostate Cancer Diagnosis and Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Prostate Cancer Diagnosis and Therapy Market Share by Players (2019-2024)
Table 18. Global Top Prostate Cancer Diagnosis and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnosis and Therapy as of 2023)
Table 19. Ranking of Global Top Prostate Cancer Diagnosis and Therapy Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Prostate Cancer Diagnosis and Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Prostate Cancer Diagnosis and Therapy Product Solution and Service
Table 23. Date of Enter into Prostate Cancer Diagnosis and Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prostate Cancer Diagnosis and Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Prostate Cancer Diagnosis and Therapy Revenue Market Share by Type (2019-2024)
Table 27. Global Prostate Cancer Diagnosis and Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Prostate Cancer Diagnosis and Therapy Revenue Market Share by Type (2025-2030)
Table 29. Global Prostate Cancer Diagnosis and Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Prostate Cancer Diagnosis and Therapy Revenue Market Share by Application (2019-2024)
Table 31. Global Prostate Cancer Diagnosis and Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Prostate Cancer Diagnosis and Therapy Revenue Market Share by Application (2025-2030)
Table 33. North America Prostate Cancer Diagnosis and Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Prostate Cancer Diagnosis and Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Prostate Cancer Diagnosis and Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Prostate Cancer Diagnosis and Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Prostate Cancer Diagnosis and Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Prostate Cancer Diagnosis and Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Prostate Cancer Diagnosis and Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Prostate Cancer Diagnosis and Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Prostate Cancer Diagnosis and Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 48. AbbVie Company Detail
Table 49. AbbVie Business Overview
Table 50. AbbVie Prostate Cancer Diagnosis and Therapy Product
Table 51. AbbVie Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024) & (US$ Million)
Table 52. AbbVie Recent Development
Table 53. Astellas Pharma Company Detail
Table 54. Astellas Pharma Business Overview
Table 55. Astellas Pharma Prostate Cancer Diagnosis and Therapy Product
Table 56. Astellas Pharma Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024) & (US$ Million)
Table 57. Astellas Pharma Recent Development
Table 58. AstraZeneca Company Detail
Table 59. AstraZeneca Business Overview
Table 60. AstraZeneca Prostate Cancer Diagnosis and Therapy Product
Table 61. AstraZeneca Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024) & (US$ Million)
Table 62. AstraZeneca Recent Development
Table 63. Bayer Company Detail
Table 64. Bayer Business Overview
Table 65. Bayer Prostate Cancer Diagnosis and Therapy Product
Table 66. Bayer Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024) & (US$ Million)
Table 67. Bayer Recent Development
Table 68. Dendreon Pharmaceuticals Company Detail
Table 69. Dendreon Pharmaceuticals Business Overview
Table 70. Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Product
Table 71. Dendreon Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024) & (US$ Million)
Table 72. Dendreon Pharmaceuticals Recent Development
Table 73. Ferring Company Detail
Table 74. Ferring Business Overview
Table 75. Ferring Prostate Cancer Diagnosis and Therapy Product
Table 76. Ferring Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024) & (US$ Million)
Table 77. Ferring Recent Development
Table 78. Ipsen Pharma Company Detail
Table 79. Ipsen Pharma Business Overview
Table 80. Ipsen Pharma Prostate Cancer Diagnosis and Therapy Product
Table 81. Ipsen Pharma Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024) & (US$ Million)
Table 82. Ipsen Pharma Recent Development
Table 83. Johnson and Johnson Company Detail
Table 84. Johnson and Johnson Business Overview
Table 85. Johnson and Johnson Prostate Cancer Diagnosis and Therapy Product
Table 86. Johnson and Johnson Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024) & (US$ Million)
Table 87. Johnson and Johnson Recent Development
Table 88. Sanofi Company Detail
Table 89. Sanofi Business Overview
Table 90. Sanofi Prostate Cancer Diagnosis and Therapy Product
Table 91. Sanofi Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024) & (US$ Million)
Table 92. Sanofi Recent Development
Table 93. Tolmar Pharmaceuticals Company Detail
Table 94. Tolmar Pharmaceuticals Business Overview
Table 95. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Product
Table 96. Tolmar Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Therapy Business (2019-2024) & (US$ Million)
Table 97. Tolmar Pharmaceuticals Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Diagnosis and Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Prostate Cancer Diagnosis and Therapy Market Share by Type: 2023 VS 2030
Figure 3. Hormone Therapy Features
Figure 4. Chemotherapy Features
Figure 5. Biologic Therapy Features
Figure 6. Targeted Therapy Features
Figure 7. Global Prostate Cancer Diagnosis and Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Prostate Cancer Diagnosis and Therapy Market Share by Application: 2023 VS 2030
Figure 9. General Hospitals Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Prostate Cancer Diagnosis and Therapy Report Years Considered
Figure 12. Global Prostate Cancer Diagnosis and Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Prostate Cancer Diagnosis and Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Prostate Cancer Diagnosis and Therapy Market Share by Region: 2023 VS 2030
Figure 15. Global Prostate Cancer Diagnosis and Therapy Market Share by Players in 2023
Figure 16. Global Top Prostate Cancer Diagnosis and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnosis and Therapy as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnosis and Therapy Revenue in 2023
Figure 18. North America Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Prostate Cancer Diagnosis and Therapy Market Share by Country (2019-2030)
Figure 20. United States Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Prostate Cancer Diagnosis and Therapy Market Share by Country (2019-2030)
Figure 24. Germany Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Share by Region (2019-2030)
Figure 32. China Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Prostate Cancer Diagnosis and Therapy Market Share by Country (2019-2030)
Figure 40. Mexico Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Share by Country (2019-2030)
Figure 44. Turkey Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. AbbVie Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
Figure 47. Astellas Pharma Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
Figure 48. AstraZeneca Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
Figure 49. Bayer Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
Figure 50. Dendreon Pharmaceuticals Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
Figure 51. Ferring Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
Figure 52. Ipsen Pharma Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
Figure 53. Johnson and Johnson Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
Figure 54. Sanofi Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
Figure 55. Tolmar Pharmaceuticals Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
